Home › FDA Panel Backs Inhaler Drug For Lung Disease
 

Keywords :   


FDA Panel Backs Inhaler Drug For Lung Disease

2013-04-18 17:01:14| Biotech - Topix.net

A panel of respiratory experts voted Wednesday in favor of approving an experimental inhaler drug from GlaxoSmithKline and Theravance for treating chronic lung disease.

Tags: panel drug disease lung

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
26.11Electric car targets could be eased as demand flags
26.11PPG Completes Sale of Silicas Products Business to QEMETICA
26.11EPA releases draft farm emissions methodologies
26.11GibsonSG
26.11Dimarzio DP419 area67 2
26.11110
26.11
26.11tnqnp671
More »